ABSTRACT
Neurocristopathies form a specific group of rare genetic diseases in which a defect in neural crest cell development is causal. Because of the large number of neural crest cell derivatives, distinct structures/cell types (isolated or in combination) are affected in each neurocristopathy. The most important issues in this research field is that the underlying genetic cause and associated pathogenic mechanism of most cases of neurocristopathy are poorly understood. This article describes how a relatively simple insertional mutagenesis approach in the mouse has proved useful for identifying new candidate genes and pathogenic mechanisms for diverse neurocristopathies.
Disclosure of potential conflicts of interest
No potential conflicts of interest were disclosed.
Acknowledgments
The author thanks David W. Silversides in whose laboratory the transgenic mice were generated.
Funding
The Pilon laboratory is funded by grants from the Canadian Institute of Health Research (CIHR), the Natural Science and Engineering Research Council of Canada (NSERC), the Fonds de la recherche du Québec – Santé (FRQS) and the Fondation du grand défi Pierre Lavoie.